MedTrace Logo

Japan Morning Surge-1 Study

NCT00285519 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2006-02-02

No results posted yet for this study

Summary

The purpose of this study is to examine whether strict blood pressure (BP) control by doxazosin using home BP monitoring, especially targeting the morning BP level, can reduce hypertensive target organ damage.

Conditions

Interventions

DRUG

Doxazosin (drug)

Sponsors & Collaborators

  • Japan Heart Foundation

    lead OTHER

Principal Investigators

  • Kazuomi Kario, MD, PhD · Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Completion
2005-08-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00285519 on ClinicalTrials.gov